Physician

Glenn B. Mieszkalski

According to 2025 Medicare claims, Glenn Mieszkalski (NPI: 1043325657) practices radiation oncology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is THE CENTERS FOR ADVANCED UROLOGY, LLP (NPI: 1295565356; TIN: 474352018) and primary practice location at 17604-3200. Mieszkalski is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Mieszkalski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 167 traditional Medicare patients, billed 4,346 HCPCS/CPT codes, and received $507,541 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 168 prescription claims across 57 beneficiaries totaling $2,850 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $61,997 and ending at $507,541. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,132 to $2,850. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$344K$687K2015 Medicare payment: $61,997 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $139,436 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $473,177 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $567,716 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $564,842 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $613,806 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $564,212 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $687,458 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $385,668 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $507,541 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015177909$61,997
20161871,551$139,436
20171955,315$473,177
20181436,184$567,716
20191436,721$564,842
20201135,994$613,806
20211365,302$564,212
20221837,967$687,458
20232064,485$385,668
20241674,346$507,541

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4K$2.9K2015 Drug cost: $1,132 (USD; Tot_Drug_Cst)2016 Drug cost: $1,224 (USD; Tot_Drug_Cst)2017 Drug cost: $1,273 (USD; Tot_Drug_Cst)2018 Drug cost: $380 (USD; Tot_Drug_Cst)2019 Drug cost: $605 (USD; Tot_Drug_Cst)2020 Drug cost: $569 (USD; Tot_Drug_Cst)2021 Drug cost: $1,344 (USD; Tot_Drug_Cst)2022 Drug cost: $1,303 (USD; Tot_Drug_Cst)2023 Drug cost: $2,048 (USD; Tot_Drug_Cst)2024 Drug cost: $2,850 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152255$1,132
20162070$1,224
20172483$1,273
20181533$380
2019N/R13$605
2020N/R11$569
20214498$1,344
202244121$1,303
202355135$2,048
202457168$2,850

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions56209$143
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more4949$129
77263Complex radiation therapy planning6567$126
77334Design and construction of complex radiation treatment device55120$46
77014Ct guidance for insertion of radiation therapy fields45634$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl1045,730$1,477
Lidocaine Hcl ViscousLidocaine Hcl15113$289

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Glenn B. Mieszkalski?

Tedicare shows public-source Medicare data for Glenn B. Mieszkalski (NPI 1043325657), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Glenn B. Mieszkalski have ACO affiliation data?

Glenn B. Mieszkalski is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Glenn B. Mieszkalski?

Glenn B. Mieszkalski is linked to THE CENTERS FOR ADVANCED UROLOGY, LLP (billing NPI 1295565356) in the available physician profile data.

Does Glenn B. Mieszkalski have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.